Started in FY22 to categorize with the goal of determining assets and liabilities for the new management team and reducing SRNL's excess inventory. • Allow for program growth within the current material limits. • Prior to FY22 inventory was a 'blackbox'. • No formal system for tracking utilization or future needs until items arrived. • Created friction between management and researchers • Slowed down incoming projects • Risk of breaking safety and/or security limits • Risk of jepardizing program growth.
No takes yet. Share an insight, caveat, or question.
Ramsey et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: